Drilldown: Medicines
Medicines > fda max 
:
10 mg/d (5 mg if severe renal or moderate hepatic impairment, or strong CYP3A4 inhibitors) or
20 mg/d
& duration:
Daily dosing; active metabolites with very long half-lives (up to 1-3 weeks)
:
10 mg/d (5 mg if severe renal or moderate hepatic impairment, or strong CYP3A4 inhibitors) or
20 mg/d
& duration:
Daily dosing; active metabolites with very long half-lives (up to 1-3 weeks) Use the filters below to narrow your results.
generic:
(There are no values for this filter)
brand:
(There are no values for this filter)
classes:
(There are no values for this filter)
mechanism:
(There are no values for this filter)
uses:
(There are no values for this filter)
starting dose:
(There are no values for this filter)
preparations:
(There are no values for this filter)
fda max: (Click arrow to add another value)
routes:
(There are no values for this filter)
onset:
(There are no values for this filter)
duration: (Click arrow to add another value)
halflife:
(There are no values for this filter)
bioavailability:
(There are no values for this filter)
pregnancy:
(There are no values for this filter)
legal:
(There are no values for this filter)
There are no results for this report.